278 related articles for article (PubMed ID: 35089585)
21. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
22. Development of a recombinant vaccine containing a spike S1-Fc fusion protein induced protection against MERS-CoV in human DPP4 knockin transgenic mice.
Jung BK; An Y; Park JE; Chang KS; Jang H
J Virol Methods; 2022 Jan; 299():114347. PubMed ID: 34728273
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice.
Kim E; Okada K; Kenniston T; Raj VS; AlHajri MM; Farag EA; AlHajri F; Osterhaus AD; Haagmans BL; Gambotto A
Vaccine; 2014 Oct; 32(45):5975-82. PubMed ID: 25192975
[TBL] [Abstract][Full Text] [Related]
24. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
Hashem AM; Algaissi A; Agrawal AS; Al-Amri SS; Alhabbab RY; Sohrab SS; S Almasoud A; Alharbi NK; Peng BH; Russell M; Li X; Tseng CK
J Infect Dis; 2019 Oct; 220(10):1558-1567. PubMed ID: 30911758
[TBL] [Abstract][Full Text] [Related]
25. Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model.
Bodmer BS; Fiedler AH; Hanauer JRH; Prüfer S; Mühlebach MD
Virology; 2018 Aug; 521():99-107. PubMed ID: 29902727
[TBL] [Abstract][Full Text] [Related]
26. Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus.
Patel A; Reuschel EL; Xu Z; Zaidi FI; Kim KY; Scott DP; Mendoza J; Ramos S; Stoltz R; Feldmann F; Okumura A; Meade-White K; Haddock E; Thomas T; Rosenke R; Lovaglio J; Hanley PW; Saturday G; Muthumani K; Feldmann H; Humeau LM; Broderick KE; Weiner DB
JCI Insight; 2021 May; 6(10):. PubMed ID: 33886507
[TBL] [Abstract][Full Text] [Related]
27. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
[TBL] [Abstract][Full Text] [Related]
28. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
Kato H; Takayama-Ito M; Iizuka-Shiota I; Fukushi S; Posadas-Herrera G; Horiya M; Satoh M; Yoshikawa T; Yamada S; Harada S; Fujii H; Shibamura M; Inagaki T; Morimoto K; Saijo M; Lim CK
PLoS One; 2019; 14(10):e0223684. PubMed ID: 31589656
[TBL] [Abstract][Full Text] [Related]
29. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
Dai L; Zheng T; Xu K; Han Y; Xu L; Huang E; An Y; Cheng Y; Li S; Liu M; Yang M; Li Y; Cheng H; Yuan Y; Zhang W; Ke C; Wong G; Qi J; Qin C; Yan J; Gao GF
Cell; 2020 Aug; 182(3):722-733.e11. PubMed ID: 32645327
[TBL] [Abstract][Full Text] [Related]
30. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.
Schindewolf C; Menachery VD
Viruses; 2019 Jan; 11(1):. PubMed ID: 30658390
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
Ong E; Wong MU; Huffman A; He Y
Front Immunol; 2020; 11():1581. PubMed ID: 32719684
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.
Al-Amri SS; Abbas AT; Siddiq LA; Alghamdi A; Sanki MA; Al-Muhanna MK; Alhabbab RY; Azhar EI; Li X; Hashem AM
Sci Rep; 2017 Mar; 7():44875. PubMed ID: 28332568
[TBL] [Abstract][Full Text] [Related]
33. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection.
Jia W; Channappanavar R; Zhang C; Li M; Zhou H; Zhang S; Zhou P; Xu J; Shan S; Shi X; Wang X; Zhao J; Zhou D; Perlman S; Zhang L
Emerg Microbes Infect; 2019; 8(1):760-772. PubMed ID: 31130102
[TBL] [Abstract][Full Text] [Related]
34. Current advancements and potential strategies in the development of MERS-CoV vaccines.
Zhang N; Jiang S; Du L
Expert Rev Vaccines; 2014 Jun; 13(6):761-74. PubMed ID: 24766432
[TBL] [Abstract][Full Text] [Related]
35. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.
Cho H; Excler JL; Kim JH; Yoon IK
Hum Vaccin Immunother; 2018 Feb; 14(2):304-313. PubMed ID: 29048984
[TBL] [Abstract][Full Text] [Related]
36. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Zhang C; Zhou C; Shi L; Liu G
Hum Vaccin Immunother; 2020 Oct; 16(10):2366-2369. PubMed ID: 32961082
[TBL] [Abstract][Full Text] [Related]
37. Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.
Begum J; Mir NA; Dev K; Buyamayum B; Wani MY; Raza M
Transbound Emerg Dis; 2021 May; 68(3):1111-1124. PubMed ID: 32815655
[TBL] [Abstract][Full Text] [Related]
38. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
[TBL] [Abstract][Full Text] [Related]
39. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.
Okba NMA; Widjaja I; van Dieren B; Aebischer A; van Amerongen G; de Waal L; Stittelaar KJ; Schipper D; Martina B; van den Brand JMA; Beer M; Bosch BJ; Haagmans BL
Emerg Microbes Infect; 2020 Dec; 9(1):1080-1091. PubMed ID: 32471334
[TBL] [Abstract][Full Text] [Related]
40. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.
Ma C; Wang L; Tao X; Zhang N; Yang Y; Tseng CK; Li F; Zhou Y; Jiang S; Du L
Vaccine; 2014 Oct; 32(46):6170-6176. PubMed ID: 25240756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
